Published in
American Association for the Advancement of Science, Science Translational Medicine, 532(12), 2020
DOI: 10.1126/scitranslmed.aay1005
Links
Tools
Blood natural killer cell deficiency reveals an immunotherapy strategy for atopic dermatitis
Journal article published in 2020 by
Madison R. Mack 
,
Jonathan R. Brestoff ,
Melissa M. Berrien-Elliott ,
Anna M. Trier ,
Ting-Lin B. Yang ,
Matthew McCullen ,
Patrick L. Collins ,
Haixia Niu,
Nancy D. Bodet,
Julia A. Wagner,
Eugene Park ,
Amy Z. Xu,
Fang Wang,
Rebecca Chibnall,
M. Laurin Council
and other authors.
,
Jonathan R. Brestoff ,
Melissa M. Berrien-Elliott ,
Anna M. Trier ,
Ting-Lin B. Yang ,
Matthew McCullen ,
Patrick L. Collins ,
Haixia Niu,
Nancy D. Bodet,
Julia A. Wagner,
Eugene Park ,
Amy Z. Xu,
Fang Wang,
Rebecca Chibnall,
M. Laurin Council
and other authors.
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 
Abstract
Patients with atopic dermatitis harbor deficiencies in subsets of NK cells that can be therapeutically reversed to improve disease in mice.